X-47915237-G-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_007137.5(ZNF81):c.591G>T(p.Lys197Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0001 in 1,208,517 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 37 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000045 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.00011 ( 0 hom. 35 hem. )
Consequence
ZNF81
NM_007137.5 missense
NM_007137.5 missense
Scores
3
14
Clinical Significance
Conservation
PhyloP100: 1.71
Genes affected
ZNF81 (HGNC:13156): (zinc finger protein 81) This gene encodes a protein that likely functions as a transcription factor. The protein contains an N-terminal KRAB domain and several C2H2-type zinc finger motifs. Mutations in this gene cause an X-linked form of intellectual disability (MRX45). Microduplication of a region of chromosome X including this gene has also been associated with other forms of intellectual disability. [provided by RefSeq, Jul 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.17487004).
BS2
High Hemizygotes in GnomAd4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF81 | NM_007137.5 | c.591G>T | p.Lys197Asn | missense_variant | 5/5 | ENST00000338637.13 | NP_009068.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF81 | ENST00000338637.13 | c.591G>T | p.Lys197Asn | missense_variant | 5/5 | 3 | NM_007137.5 | ENSP00000341151 | P1 | |
ZNF81 | ENST00000376954.6 | c.591G>T | p.Lys197Asn | missense_variant | 6/6 | 5 | ENSP00000366153 | P1 | ||
ZNF81 | ENST00000376950.4 | c.277+19297G>T | intron_variant | 5 | ENSP00000366149 |
Frequencies
GnomAD3 genomes AF: 0.0000447 AC: 5AN: 111943Hom.: 0 Cov.: 23 AF XY: 0.0000587 AC XY: 2AN XY: 34089
GnomAD3 genomes
AF:
AC:
5
AN:
111943
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
34089
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000278 AC: 5AN: 179883Hom.: 0 AF XY: 0.0000151 AC XY: 1AN XY: 66159
GnomAD3 exomes
AF:
AC:
5
AN:
179883
Hom.:
AF XY:
AC XY:
1
AN XY:
66159
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000106 AC: 116AN: 1096574Hom.: 0 Cov.: 31 AF XY: 0.0000966 AC XY: 35AN XY: 362256
GnomAD4 exome
AF:
AC:
116
AN:
1096574
Hom.:
Cov.:
31
AF XY:
AC XY:
35
AN XY:
362256
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000447 AC: 5AN: 111943Hom.: 0 Cov.: 23 AF XY: 0.0000587 AC XY: 2AN XY: 34089
GnomAD4 genome
AF:
AC:
5
AN:
111943
Hom.:
Cov.:
23
AF XY:
AC XY:
2
AN XY:
34089
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ExAC
AF:
AC:
3
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 16, 2023 | The c.591G>T (p.K197N) alteration is located in exon 5 (coding exon 4) of the ZNF81 gene. This alteration results from a G to T substitution at nucleotide position 591, causing the lysine (K) at amino acid position 197 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T
FATHMM_MKL
Benign
D
LIST_S2
Benign
.;T
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M
MutationTaster
Benign
N;N
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
D;D
Vest4
MutPred
Loss of methylation at K197 (P = 0.0188);Loss of methylation at K197 (P = 0.0188);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at